No abstract

No abstract

The mean glandular doses (MGD) to samples of women attending for mammographic screening are measured routinely at screening centres in the UK Breast Screening Programme (NHSBSP). This paper reviews a large representative sample of dose measurements collected during screening in the NHSBSP in 2001 and 2002 for 53 218 films, using 290 X-ray sets, for 16 505 women. The average MGD was 2.23 mGy per oblique film and 1.96 mGy per craniocaudal film; similar to those found previously in the NHSBSP for the years 1997 and 1998. Increasing use of sophisticated units with automatic beam quality selection has reduced the radiation dose received by large breasts, with only 2% of oblique mammograms having doses in excess of 5 mGy. The increasing use of large format film has also reduced the doses to this sub-group. However the total dose per woman has increased due to the introduction of two view screening at every visit. The MGD to the standard breast was found to vary from 0.76 mGy to 2.29 mGy, with 97% of units below the recommended upper limit of 2 mGy, illustrating the benefit of strict quality control. A reduction in dose of 3% was observed between the age bands 50-54 years and 60-64 years. This study has confirmed that the proposed national diagnostic reference level (NDRL) of 3.5 mGy for 55 mm thick breasts is an appropriate value to identify systems giving unusually high doses, with just 3.5% of systems exceeding this level. In most cases these higher doses were explained by the design of one particular make of X-ray set and its mode of operation. Average doses for oblique views of average sized breasts were fairly well correlated with the dose to the standard breast, and typically 42% higher. This highlights the need for a revised definition of the standard breast used in the UK to better reflect the exposure factors and doses received in clinical practice.

An experimental method of determining the optimal beam quality for digital mammography systems was applied to two systems (Fuji Profect and GE Senographe 2000D). The mean glandular dose (MGD) and contrast-to-noise ratio (CNR) were measured using Perspex breast phantoms simulating breasts from 20 mm to 90 mm thick. For each thickness, four combinations of tube voltage and target/filter were tested. Optimal beam quality was defined as giving a target CNR for the lowest MGD and was similar for the two systems. For breasts with a thickness of 21 mm or 32 mm, a tube voltage of either 25 kV or 28 kV and a Mo/Mo target/filter combination was optimal. For breast thicknesses of 45 mm and greater, the combination that had the highest X-ray energy (34 kV Rh/Rh) was optimal. Optimization using the higher energy beam quality required greater detector dose to compensate for the lower contrast. Thus for a 75 mm thick breast the 34 kV Rh/Rh combination required about a 90% greater detector dose than 28 kV Mo/Mo to achieve the same CNR because of the 25% reduction in contrast. Nonetheless, the MGD was reduced by 32% by choosing the higher energy spectra and achieving the same CNR. Current automatic exposure control (AEC) designs that aim for a fixed detector dose are not optimal and greater use of higher energy spectra should be accompanied by higher detector doses at all breast thicknesses which are average or above. This may result in slightly higher doses, but better image quality for these breasts.

Changes in the radiation dose in breast screening over time have been determined. Specifically, the impact on radiation dose of introducing different types of DR and computed radiography system into breast screening has been quantified.